Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KURA Kura Oncology

Pre-Market Trading 12-23 04:55:00 EST

9.01

+0.04

+0.45%

High9.17	Low8.88	Vol3.20M
Open8.92	D1 Closing8.97	Amplitude3.23%
Mkt Cap700.65M	Tradable Cap446.46M	Total Shares77.76M
T/O28.88M	T/O Rate6.47%	Tradable Shares49.55M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology","latestPrice":9.01,"timestamp":1734728400000,"preClose":8.97,"halted":0,"volume":3204000,"delay":0,"floatShares":49551776,"shares":77763750,"eps":-2.359653,"marketStatus":"Pre-Market Trading","change":0.04,"latestTime":"12-23 04:55:00 EST","open":8.92,"high":9.17,"low":8.88,"amount":28878395.328,"amplitude":0.03233,"askPrice":10.6,"askSize":100,"bidPrice":8.86,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-2.359653,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1734964200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1446699600000,"exchange":"NASDAQ","adjPreClose":9.01,"postHourTrading":{"tag":"盘后","latestPrice":9.1738,"preClose":9.01,"latestTime":"19:14 EST","volume":215161,"amount":1938790.802,"timestamp":1734740087768},"volumeRatio":1.3116366218295552,"impliedVol":0.8884,"impliedVolPercentile":0.86},"requestUrl":"/m/hq/s/KURA","defaultTab":"news","newsList":[{"id":"2490029639","title":"Kura Oncology’s Promising Clinical Advances and Strategic Pipeline Developments Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2490029639","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490029639?lang=en_us&edition=fundamental","pubTime":"2024-12-11 05:15","pubTimestamp":1733865312,"startTime":"0","endTime":"0","summary":"Kura Oncology (KURA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Zhu from LifeS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kura-oncologys-promising-clinical-advances-and-strategic-pipeline-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kura-oncologys-promising-clinical-advances-and-strategic-pipeline-developments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2490953702","title":"Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490953702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490953702?lang=en_us&edition=fundamental","pubTime":"2024-12-10 03:20","pubTimestamp":1733772010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stoke Therapeutics (STOK – Research Report) and Kura...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-stoke-therapeutics-stok-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-stoke-therapeutics-stok-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","KURA","HCSG","BK4505","STOK"],"gpt_icon":0},{"id":"2490708176","title":"Promising Clinical Trial Developments in Kura Oncology’s Ziftomenib for AML Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2490708176","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490708176?lang=en_us&edition=fundamental","pubTime":"2024-12-10 00:55","pubTimestamp":1733763310,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Kura Oncology (KURA – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-clinical-trial-developments-in-kura-oncologys-ziftomenib-for-aml-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-clinical-trial-developments-in-kura-oncologys-ziftomenib-for-aml-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2490273677","title":"Jefferies Reaffirms Their Buy Rating on Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490273677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490273677?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:25","pubTimestamp":1733750737,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Kura Oncology (KURA – Research Report) today and set a price target of $28.00. The company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2490729230","title":"Kura Oncology, Kyowa Kirin report data on KOMET-007 at ASH meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729230?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:24","pubTimestamp":1733747066,"startTime":"0","endTime":"0","summary":"Kura Oncology (KURA) and Kyowa Kirin provided encouraging clinical data from KOMET-007, a Phase 1 dose-escalation trial of ziftomenib, a highly sel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-kyowa-kirin-report-data-on-komet-007-at-ash-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-kyowa-kirin-report-data-on-komet-007-at-ash-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2463526074.USD","KURA","ASH","BK4109","BK4505"],"gpt_icon":0},{"id":"2490882726","title":"Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490882726","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490882726?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:00","pubTimestamp":1733745600,"startTime":"0","endTime":"0","summary":"– Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in KMT2A-r 1L adverse risk AML with 7+3 – – 100% of 1L NPM1-m and 96% of 1L KMT2A-r AML patients aliv","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/09/2993609/35186/en/Kura-Oncology-and-Kyowa-Kirin-Report-Positive-Combination-Data-for-Ziftomenib-at-American-Society-of-Hematology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTI","BK4161","BK4117","LU0054578231.USD","BK4109","BK4179","BK4505","KURA","LU0300736492.USD","LU2463526074.USD","LU0053671581.USD","ASH","CR","BK4139","LU0300736062.USD","BK4107","AFG"],"gpt_icon":0},{"id":"2490145794","title":"Kura Oncology holds a pharmaceutical update conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2490145794","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490145794?lang=en_us&edition=fundamental","pubTime":"2024-12-09 12:15","pubTimestamp":1733717706,"startTime":"0","endTime":"0","summary":"Management discusses the KOMET-007 combination trial of the Company’s oral and selective menin inhibitor, ziftomenib, on a conference call to be he...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-holds-a-pharmaceutical-update-conference-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-holds-a-pharmaceutical-update-conference-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2489323732","title":"Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2489323732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489323732?lang=en_us&edition=fundamental","pubTime":"2024-12-08 22:50","pubTimestamp":1733669404,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Janux Therapeutics Inc (JANX – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-janux-therapeutics-inc-janx-and-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-janux-therapeutics-inc-janx-and-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4539","JANX","BK4137","BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2489352662","title":"Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Cooper Co (COO) and Ironwood Pharma (IRWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2489352662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489352662?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:14","pubTimestamp":1733494478,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kura Oncology (KURA – Research Report), Cooper Co (C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kura-oncology-kura-cooper-co-coo-and-ironwood-pharma-irwd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kura-oncology-kura-cooper-co-coo-and-ironwood-pharma-irwd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2272731782.SGD","IRWD","HCSG","BK4137","BK4198","LU1992135472.HKD","COO","BK4588","GB00BDT5M118.USD","KURA","LU2211815571.USD","LU2272731600.USD","LU1992135399.USD","BK4505","BK4585"],"gpt_icon":0},{"id":"2489912319","title":"Kura Oncology management to meet with Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2489912319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489912319?lang=en_us&edition=fundamental","pubTime":"2024-12-05 05:40","pubTimestamp":1733348409,"startTime":"0","endTime":"0","summary":"Analyst Watsek holds a group dinner meeting with President & CEO Wilson and CCO Powl in San Diego on December 7 hosted by Cantor Fitzgerald. Publis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-management-to-meet-with-cantor-fitzgerald-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-management-to-meet-with-cantor-fitzgerald-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2489484481","title":"Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489484481","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489484481?lang=en_us&edition=fundamental","pubTime":"2024-12-05 02:25","pubTimestamp":1733336729,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.In this article, we are going to take a look at where Kura Oncology, Inc.  stands against the other small-cap biotech stocks.Revolutionizing Healthcare and Economy: The Rapid Growth of Biotechnology. The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance. Advances in fields like gene editing, sequencing, personalized medicine, and artificial intelligence are making new techniques possible, while the aging population and growing healthcare demands are driving a robust market for new treatments. According to a report by McKinsey & Company, venture capital firms made approximately $52 billion in global investments in therapeutic-focused biotech companies between 2019 and 2021. Two-thirds of this sum was given to platform-tech start-up companies.This year  started strongly for the biotechnology","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/n.oUXNhVemHQykGUTwECwA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bae76fbc6e0397669f68590458419a87","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/n.oUXNhVemHQykGUTwECwA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bae76fbc6e0397669f68590458419a87"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-kura-oncology-inc-kura-182529873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","CAGR","NQmain","KURA","QLD","MNQmain","SQQQ","BK4139","TQQQ","QID",".IXIC","BK4159","BK4505"],"gpt_icon":1},{"id":"2488675639","title":"Kura Oncology to Host Virtual Investor Event on December 9, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2488675639","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488675639?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142600,"startTime":"0","endTime":"0","summary":"Live webcast and conference call to discuss presentation of updated data from KOMET-007 combination trial of ziftomenib at ASHSAN DIEGO, Dec.  02, 2024  (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989696/35186/en/Kura-Oncology-to-Host-Virtual-Investor-Event-on-December-9-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","HST","BK4139","BK4218","BK4109","KURA","ASH","BK4588","BK4585","WRD","BK4181","LU2463526074.USD"],"gpt_icon":0},{"id":"2486979550","title":"Stifel Nicolaus Keeps Their Hold Rating on Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2486979550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486979550?lang=en_us&edition=fundamental","pubTime":"2024-11-26 10:05","pubTimestamp":1732586716,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Bradley Canino from Stifel Nicolaus maintained a Hold rating on Kura Oncology (KURA – Research Report), with a pric...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-hold-rating-on-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-hold-rating-on-kura-oncology-kura?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA","SF"],"gpt_icon":0},{"id":"2486108563","title":"Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2486108563","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486108563?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:30","pubTimestamp":1732537800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  25, 2024  (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatmen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/25/2986571/35186/en/Kura-Oncology-to-Participate-in-JMP-Securities-Hematology-and-Oncology-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","BK4211","KURA","JMP","BK4127","BK4139","BK4505"],"gpt_icon":1},{"id":"2486872737","title":"Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Bruker (BRKR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2486872737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486872737?lang=en_us&edition=fundamental","pubTime":"2024-11-25 13:50","pubTimestamp":1732513816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kura Oncology (KURA – Research Report), Bruker (BRKR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-kura-oncology-kura-bruker-brkr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-kura-oncology-kura-bruker-brkr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRKR","BK4139","LU1815336091.USD","BK4505","BK4137","LU0757428866.USD","HCSG","BK4121","KURA"],"gpt_icon":0},{"id":"2485207233","title":"Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2485207233","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485207233?lang=en_us&edition=fundamental","pubTime":"2024-11-23 23:42","pubTimestamp":1732376546,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds.In this article, we are going to take a look at where Kura Oncology, Inc.  stands against the other promising cancer stocks.According to the World Health Organization , cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide. Moreover, the World Cancer Research Fund reports that approximately 18.1 million cancer cases were diagnosed that year, with the age-standardized rate, when considering all cancers except non-melanoma skin cancer and combining data for both men and women, came in at 190 cases per 100,000 individuals. This rate was notably higher in men, with 206.9 cases per 100,000, compared to 178.1 per 100,000 in women.Since there is no universal cure for cancer, developing a drug capable of treating multiple cancer types is incredibly lucrative. This dynamic fuels continuous breakthroughs in the on","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/n.oUXNhVemHQykGUTwECwA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bae76fbc6e0397669f68590458419a87","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/n.oUXNhVemHQykGUTwECwA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bae76fbc6e0397669f68590458419a87"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kura-oncology-inc-kura-among-154226325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","KURA","TQQQ","QLD","PSQ","MNQmain",".IXIC","CAGR","NQmain","BK4139","BK4159","SQQQ","BK4505"],"gpt_icon":1},{"id":"2485425465","title":"BofA lowers Kura Oncology price target to $29, sees buying opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2485425465","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485425465?lang=en_us&edition=fundamental","pubTime":"2024-11-22 20:15","pubTimestamp":1732277725,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Zemansky lowered the firm’s price target on Kura Oncology (KURA) to $29 from $36 and keeps a Buy rating on the shares after the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-lowers-kura-oncology-price-target-to-29-sees-buying-opportunity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-lowers-kura-oncology-price-target-to-29-sees-buying-opportunity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2485903255","title":"Kura Oncology Inc : Bofa Global Research Cuts Price Objective to $29 From $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2485903255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485903255?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:19","pubTimestamp":1732274386,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2485410494","title":"Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2485410494","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485410494?lang=en_us&edition=fundamental","pubTime":"2024-11-22 01:32","pubTimestamp":1732210342,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/24/11/42119233/crude-oil-gains-15-deere-posts-better-than-expected-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTI","QUBT","CLCO","PYXS","DE","KURA","SNOW"],"gpt_icon":1},{"id":"2485941010","title":"Kura Oncology: A Contender In The Field Of Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2485941010","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485941010?lang=en_us&edition=fundamental","pubTime":"2024-11-22 01:26","pubTimestamp":1732209996,"startTime":"0","endTime":"0","summary":"Kura Oncology's partnership with Kyowa Kirin centered on ziftomenib offers long-term benefits, however, commercialization and significant royalties will take time to materialize.Ziftomenib, Kura's mos","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2121761211/image_2121761211.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2121761211/image_2121761211.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4739375-kura-oncology-a-contender-in-the-field-of-precision-medicine","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":-0.0644},{"period":"1month","weight":-0.4337},{"period":"3month","weight":-0.5699},{"period":"6month","weight":-0.5697},{"period":"1year","weight":-0.2832},{"period":"ytd","weight":-0.3734}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037302},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03336},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.017219},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.03462},{"month":5,"riseRate":0.555556,"avgChangeRate":0.031537},{"month":6,"riseRate":0.444444,"avgChangeRate":0.040223},{"month":7,"riseRate":0.444444,"avgChangeRate":0.036126},{"month":8,"riseRate":0.444444,"avgChangeRate":0.040112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.121116},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.10353},{"month":11,"riseRate":0.777778,"avgChangeRate":0.037745},{"month":12,"riseRate":0.5,"avgChangeRate":0.021169}],"exchange":"NASDAQ","name":"Kura Oncology","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kura Oncology(KURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kura Oncology,KURA,Kura Oncology股票,Kura Oncology股票老虎,Kura Oncology股票老虎国际,Kura Oncology行情,Kura Oncology股票行情,Kura Oncology股价,Kura Oncology股市,Kura Oncology股票价格,Kura Oncology股票交易,Kura Oncology股票购买,Kura Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kura Oncology(KURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}